Epigenetic alterations fuel brain metastasis via regulating inflammatory cascade

Area of Science:

• Oncology
• Neuroscience
• Epigenetics

Background:

• Brain metastasis (BrM) poses a significant survival threat to patients with melanoma, breast, and lung cancers.
• Circulating tumor cells (CTCs) breach the blood-brain barrier (BBB) to colonize the brain.
• Both genetic and epigenetic alterations are crucial in cancer metastasis.

Purpose of the Study:

• To review epigenetic factors and mechanisms that modulate neuroinflammation in BrM.
• To understand how these epigenetic changes facilitate CTC adaptation and survival in the brain.
• To summarize potential therapeutic strategies targeting epigenetic regulation in BrM.

Main Methods:

• Literature review of studies on epigenetic modifications and neuroinflammation in BrM.
• Analysis of mechanisms by which epigenetic factors influence CTCs in the brain microenvironment.
• Synthesis of current knowledge on drugs targeting epigenetic enzymes in BrM.

Main Results:

• Epigenetic modifications play a critical role in modulating neuroinflammation during BrM.
• These epigenetic changes enable CTCs to adapt and survive within the unique brain microenvironment.
• Targeting enzymes involved in epigenetic regulation presents a promising therapeutic avenue.

Conclusions:

• Epigenetic mechanisms are key drivers of neuroinflammation and adaptation in brain metastasis.
• Targeting epigenetic enzymes offers a potential strategy for developing novel treatments for BrM.
• Further research into epigenetic modulation could improve outcomes for cancer patients with BrM.